实用癌症杂志
實用癌癥雜誌
실용암증잡지
THE PRACTICAL JOURNAL OF CANCER
2014年
5期
506-508
,共3页
刘云军%何志江%黄毅超%李文
劉雲軍%何誌江%黃毅超%李文
류운군%하지강%황의초%리문
晚期胃癌%化疗%TAM%CEA%CA72-4
晚期胃癌%化療%TAM%CEA%CA72-4
만기위암%화료%TAM%CEA%CA72-4
Advanced gastric cancer%Chemotherapy%TAM%CEA%CA72-4
目的:探索替吉奥联合奥沙利铂化疗对晚期胃癌TAM、CEA、CA72-4的影响及其临床意义。方法采用ELISA法对54例胃癌患者化疗前后血清中CEA、CA72-4进行检测;应用生化法对其血清TAM进行检测,并评定不良反应情况。结果2个化疗周期后TAM,CEA,CA72-4水平均降低,较化疗前差异具有统计学意义( P<0.05)。化疗有效的病例血清中TAM,CEA及CA72-4水平下降明显,而进展病例血清中TAM,CEA及CA72-4水平不同程度的升高,差异有统计学意义(P<0.05)。结论 TAM、CEA、CA72-4的联合检测可作为晚期胃癌化疗效果的早期预测指标。
目的:探索替吉奧聯閤奧沙利鉑化療對晚期胃癌TAM、CEA、CA72-4的影響及其臨床意義。方法採用ELISA法對54例胃癌患者化療前後血清中CEA、CA72-4進行檢測;應用生化法對其血清TAM進行檢測,併評定不良反應情況。結果2箇化療週期後TAM,CEA,CA72-4水平均降低,較化療前差異具有統計學意義( P<0.05)。化療有效的病例血清中TAM,CEA及CA72-4水平下降明顯,而進展病例血清中TAM,CEA及CA72-4水平不同程度的升高,差異有統計學意義(P<0.05)。結論 TAM、CEA、CA72-4的聯閤檢測可作為晚期胃癌化療效果的早期預測指標。
목적:탐색체길오연합오사리박화료대만기위암TAM、CEA、CA72-4적영향급기림상의의。방법채용ELISA법대54례위암환자화료전후혈청중CEA、CA72-4진행검측;응용생화법대기혈청TAM진행검측,병평정불량반응정황。결과2개화료주기후TAM,CEA,CA72-4수평균강저,교화료전차이구유통계학의의( P<0.05)。화료유효적병례혈청중TAM,CEA급CA72-4수평하강명현,이진전병례혈청중TAM,CEA급CA72-4수평불동정도적승고,차이유통계학의의(P<0.05)。결론 TAM、CEA、CA72-4적연합검측가작위만기위암화료효과적조기예측지표。
Objective To explore the effect of tegafur combined with oxaliplatin chemotherapy on TAM ,CEA and CA72-4 of advanced gastric cancer patients and its clinical significance .Methods CEA and CA72-4 in 54 patients with gastric cancer before and after chemotherapy were detected by ELISA;serum TAM of the 54 patients were detected by biochemical methods ,and adverse reactions were analyzed .Results After 2 chemotherapy cycles ,TAM,CEA and CA72-4 levels all dropped ,and the differ-ence was statistically significant(P<0.05);the TAM,CEA and CA72-4 levels of the chemotherapy effective cases decreased sig-nificantly;but the serum TAM ,CEA and CA72-4 levels of advanced cases increased in varying degrees ,the difference was statisti-cally significant(P<0.05).Conclusion Combined detection of TAM,CEA and CA72-4 can be used as an early predictive in-dex of efficacy of advanced gastric cancer patients treated with chemotherapy .